4//SEC Filing
SCHIERMEIER ANDREW 4
Accession 0001209191-18-063663
CIK 0001652130other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:23 PM ET
Size
5.5 KB
Accession
0001209191-18-063663
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Award
Stock Option (right to buy)
2018-12-18+81,000→ 81,000 totalExercise: $14.58Exp: 2028-12-17→ Common Stock (81,000 underlying)
Footnotes (1)
- [F1]This option was granted on December 18, 2018 with respect to 81,000 shares of Common Stock, with 25% vesting on December 18, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001738456
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:23 PM ET
- Size
- 5.5 KB